121 related articles for article (PubMed ID: 38829945)
21. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure.
Mani I; Alexopoulou A; Vasilieva L; Hadziyannis E; Agiasotelli D; Bei M; Alexopoulos T; Dourakis SP
Liver Int; 2019 Feb; 39(2):299-306. PubMed ID: 30261128
[TBL] [Abstract][Full Text] [Related]
22. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure.
Trieb M; Rainer F; Stadlbauer V; Douschan P; Horvath A; Binder L; Trakaki A; Knuplez E; Scharnagl H; Stojakovic T; Heinemann Á; Mandorfer M; Paternostro R; Reiberger T; Pitarch C; Amorós A; Gerbes A; Caraceni P; Alessandria C; Moreau R; Clària J; Marsche G; Stauber RE
J Hepatol; 2020 Jul; 73(1):113-120. PubMed ID: 32061870
[TBL] [Abstract][Full Text] [Related]
23. Characteristics, Diagnosis and Prognosis of Acute-on-Chronic Liver Failure in Cirrhosis Associated to Hepatitis B.
Li H; Chen LY; Zhang NN; Li ST; Zeng B; Pavesi M; Amorós À; Mookerjee RP; Xia Q; Xue F; Ma X; Hua J; Sheng L; Qiu DK; Xie Q; Foster GR; Dusheiko G; Moreau R; Gines P; Arroyo V; Jalan R
Sci Rep; 2016 May; 6():25487. PubMed ID: 27146801
[TBL] [Abstract][Full Text] [Related]
24. Peripheral T lymphocytes predict the severity and prognosis in patients with HBV-related acute-on-chronic liver failure.
Wang F; Sun W; Xiao Q; Liang C; Jiang S; Lian Y; Shao J; Tan S; Zheng S
Medicine (Baltimore); 2021 Feb; 100(5):e24075. PubMed ID: 33592861
[TBL] [Abstract][Full Text] [Related]
25. Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis.
Wang T; Tan W; Wang X; Zheng X; Huang Y; Li B; Meng Z; Gao Y; Qian Z; Liu F; Lu X; Yan H; Zheng Y; Zhang W; Yin S; Gu W; Zhang Y; Dong F; Wei J; Deng G; Xiang X; Zhou Y; Hou Y; Zhang Q; Xiong S; Liu J; Long L; Chen R; Chen J; Jiang X; Luo S; Chen Y; Jiang C; Zhao J; Ji L; Mei X; Li J; Li T; Zheng R; Zhou X; Ren H; Shi Y; Li H;
JHEP Rep; 2022 Oct; 4(10):100529. PubMed ID: 36052222
[TBL] [Abstract][Full Text] [Related]
26. The usefulness of C-reactive protein and neutrophil-to-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis.
Kwon JH; Jang JW; Kim YW; Lee SW; Nam SW; Jaegal D; Lee S; Bae SH
BMC Gastroenterol; 2015 Oct; 15():146. PubMed ID: 26498833
[TBL] [Abstract][Full Text] [Related]
27. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward.
Barosa R; Roque Ramos L; Patita M; Nunes G; Fonseca J
Rev Esp Enferm Dig; 2017 Jun; 109(6):399-405. PubMed ID: 28467096
[TBL] [Abstract][Full Text] [Related]
28. The Role of the CLIF-C OF and the 2016 MELD in Prognosis of Cirrhosis with and without Acute-on-Chronic Liver Failure.
Perdigoto DN; Figueiredo P; Tomé L
Ann Hepatol; 2019; 18(1):48-57. PubMed ID: 31113608
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a new prognostic model for patients with acute-on-chronic liver failure in intensive care unit.
Zhu ZY; Huang XH; Jiang HQ; Liu L
World J Gastroenterol; 2024 May; 30(20):2657-2676. PubMed ID: 38855159
[TBL] [Abstract][Full Text] [Related]
30. Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF).
Mezzano G; Cárdenas A; Aguilar F; Pavesi M; Solé C; Napoleone L; Graupera I; Juanola A; Carol M; Pose E; Fabrellas N; Hernaez R; Martínez J; Saliba F; Arroyo V; Sola E; Gines P
Dig Liver Dis; 2021 Jun; 53(6):738-745. PubMed ID: 33446445
[TBL] [Abstract][Full Text] [Related]
31. Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure.
Hartmann P; Lang S; Schierwagen R; Klein S; Praktiknjo M; Trebicka J; Schnabl B
Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):474-481. PubMed ID: 37198098
[TBL] [Abstract][Full Text] [Related]
32. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
Juanola A; Graupera I; Elia C; Piano S; Solé C; Carol M; Pérez-Guasch M; Bassegoda O; Escudé L; Rubio AB; Cervera M; Napoleone L; Avitabile E; Ma AT; Fabrellas N; Pose E; Morales-Ruiz M; Jiménez W; Torres F; Crespo G; Solà E; Ginès P
J Hepatol; 2022 Jan; 76(1):107-114. PubMed ID: 34530063
[TBL] [Abstract][Full Text] [Related]
33. Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.
Kerbert AJC; Verspaget HW; Navarro ÀA; Jalan R; Solà E; Benten D; Durand F; Ginès P; van der Reijden JJ; van Hoek B; Coenraad MJ;
Crit Care; 2017 Dec; 21(1):321. PubMed ID: 29268760
[TBL] [Abstract][Full Text] [Related]
34. Toward a more precise prognostic stratification in acute decompensation of cirrhosis: The Padua model 2.0.
Zanetto A; Pelizzaro F; Mion MM; Bucci M; Ferrarese A; Simioni P; Basso D; Burra P; Senzolo M
United European Gastroenterol J; 2023 Nov; 11(9):815-824. PubMed ID: 37792602
[TBL] [Abstract][Full Text] [Related]
35. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis.
Kalra A; Wedd JP; Bambha KM; Gralla J; Golden-Mason L; Collins C; Rosen HR; Biggins SW
Liver Transpl; 2017 Feb; 23(2):155-165. PubMed ID: 28006875
[TBL] [Abstract][Full Text] [Related]
37. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis.
Horvatits T; Drolz A; Roedl K; Rutter K; Ferlitsch A; Fauler G; Trauner M; Fuhrmann V
Liver Int; 2017 Feb; 37(2):224-231. PubMed ID: 27416294
[TBL] [Abstract][Full Text] [Related]
38. Risk stratification based on acute-on-chronic liver failure in cirrhotic patients hospitalized for acute variceal bleeding.
Zhu Z; Jiang H
BMC Gastroenterol; 2023 May; 23(1):148. PubMed ID: 37173645
[TBL] [Abstract][Full Text] [Related]
39. Circulating levels of pentraxin-3 (PTX3) in patients with liver cirrhosis.
Narciso-Schiavon JL; Pereira JG; Silva TE; Bansho ETO; Morato EF; Pinheiro JT; Muraro-Wildner L; Bazzo ML; Dantas-Corrêa EB; Schiavon LL
Ann Hepatol; 2017; 16(5):780-787. PubMed ID: 28809733
[TBL] [Abstract][Full Text] [Related]
40. Acute-on-chronic liver failure: A comparison of three different diagnostic criteria.
Leão GS; Lunardi FL; Picon RV; Tovo CV; de Mattos AA; de Mattos ÂZ
Ann Hepatol; 2019; 18(2):373-378. PubMed ID: 31053547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
